Skip to main content
Fig. 2 | BMC Complementary and Alternative Medicine

Fig. 2

From: A pilot single centre, double blind, placebo controlled, randomized, parallel study of Calmagen® dermaceutical cream and lotion for the topical treatment of tinea and onychomycosis

Fig. 2

Calmagen® lotion and cream met primary endpoint: mycological cure based on KOH smear, fungal culture and live spore count. a Combined results on Calmagen® cream and lotion; b Calmagen® cream sub-group results; c Calmagen® lotion sub-group results; p-value; *: statistically significant; N: Number of subjects; KOH:Potassium hydroxide; |-|: confidence interval

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us